Manufacturing Analyst Intern
AstraZeneca
Summary
We are looking for rising junior and senior level students studying a science-based discipline, engineering, business management or a related field for a 12-week internship role at our site in Rockville, MD from May 24, 2027 to August 13, 2027.
Job description
Position Description
- Project planning: Define the project scope, objectives, milestones, stakeholders, and implementation approach from initiation through pre-implementation, depending on the project's scope and level of effort.
- Process analysis: Assess the current state, identify opportunities for improvement, and evaluate potential impacts to quality, cost, time, compliance, and operational efficiency.
- Solution development: Design and develop process improvements, automation, dashboards, or other tools that address the identified business need.
- Stakeholder engagement: Collaborate with manufacturing personnel and cross-functional partners to gather requirements, validate assumptions, and incorporate feedback.
- Leadership communication: Present the proposed solution, progress, findings, and recommendations to senior leaders within the manufacturing organization, with support and guidance from the manager.
Requirements
- Rising junior and senior level students studying a science-based discipline, engineering, business management or a related field
- Proficiency with data analysis and digital innovation
- Ability to follow AI trends and support project management
- Experience using Excel and designing dashboards
- Expected graduation date after August 2027
- US Work Authorization required at time of application
- This role will not be granting CPT support
- Ability to report onsite to Rockville, MD site 5 days per week
- No relocation assistance provided
Benefits
- Compensation: $37 - $39/hour
Company overview
AstraZeneca is a global, science-led, patient-focused pharmaceutical company dedicated to accelerating the delivery of life-changing medicines that create enduring value for patients, society, and shareholders. With a workforce of over 94,300 employees worldwide, the company operates across three core therapy areas: Oncology, BioPharmaceuticals (including Cardiovascular, Renal & Metabolism, Respiratory & Immunology), and Rare Disease. Headquartered in Cambridge, UK, AstraZeneca maintains strategic R&D centers in Cambridge, Gaithersburg (US), Boston (US), Gothenburg (Sweden), Shanghai, and Beijing. The company generated $54.1 billion in total revenue in 2024 and invested $13.6 billion in scientific research and development. AstraZeneca's bold aspiration is to be pioneers in science, lead in disease areas, and transform patient outcomes, with a goal to launch 20 new medicines and achieve $80 billion in total revenue by 2030. The company is recognized for its commitment to sustainability, health equity, and creating an inclusive work environment where diverse perspectives drive innovation.